Accendra Health (ACH) Non Operating Interest Expenses (2009 - 2026)

For the trailing twelve months through Mar 31, 2026, Non Operating Interest Expenses at Accendra Health was $115.32 million, up 8.4% year-over-year; for FY2025, it came in at $107.18 million, down 0.4% from FY2024.

• Annual Non Operating Interest Expenses has declined for three consecutive years, though with a five-year compound annual growth rate of 5.1% (FY2020 to FY2025).
• In prior years, Accendra Health's Non Operating Interest Expenses was $107.57 million in FY2024 (-7.9%), $116.77 million in FY2023 (-9.4%), $128.89 million in FY2022 (+168.0%) and $48.09 million in FY2021 (-42.3%).
• The Q1 2026 figure stands as the highest quarterly Non Operating Interest Expenses since Q1 2024.
• On a year-over-year basis, Non Operating Interest Expenses has increased in each of the last four quarters, with an average decline of 8.1% over the last seven quarters.
• The strongest year-over-year quarter for Non Operating Interest Expenses in the past five years was Q4 2022, with growth of 264.1%; the weakest was Q2 2021, with a decline of 46.6%.
• According to Business Quant data, Non Operating Interest Expenses for the three prior quarters was $27.93 million (Q4 2025), $29.03 million (Q3 2025) and $26.01 million (Q2 2025).